<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Kries H</dc:creator>
  <dc:date>2016</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">From the evolutionary melting pot of natural product synthetase genes, microorganisms elicit antibiotics, communication tools, and iron scavengers. Chemical biologists manipulate these genes to recreate similarly diverse and potent biological activities not on evolutionary time scales but within months. Enzyme engineering has progressed considerably in recent years and offers new screening, modelling, and design tools for natural product designers. Here, recent advances in enzyme engineering and their application to nonribosomal peptide synthetases are reviewed. Among the nonribosomal peptides that have been subjected to biosynthetic engineering are the antibiotics daptomycin, calcium-dependent antibiotic, and gramicidin S. With these peptides, incorporation of unnatural building blocks and modulation of bioactivities via various structural modifications have been successfully demonstrated. Natural product engineering on the biosynthetic level is not a reliable method yet. However, progress in the understanding and manipulation of biosynthetic pathways may enable the routine production of optimized peptide drugs in the near future. Copyright © 2016 European Peptide Society and John Wiley &amp; Sons, Ltd.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/139919</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1002/psc.2907</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/27465074</dc:relation>
  <dc:source>Journal of peptide science : an official publication of the European Peptide Society. - 2016</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">NRPS</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">click chemistry</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">directed evolution</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">domain swap</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">enzyme engineering</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">gramicidin S</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Amino Acid Sequence</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Anti-Bacterial Agents</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Click Chemistry</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Daptomycin</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Directed Molecular Evolution</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Drug Design</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Gene Expression</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Gramicidin</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Mutation</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Peptide Synthases</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Peptides</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Protein Domains</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Protein Engineering</dc:subject>
  <dc:title xmlns:ns20="xml" ns20:lang="en">Biosynthetic engineering of nonribosomal peptide synthetases.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
